Administration of granulocyte colony-stimulating factor after myocardial infarction enhances the recruitment of hematopoietic stem cell-derived myofibroblasts and contributes to cardiac repair

Jun Fujita, Mitsuharu Mori, Hiroshi Kawada, Yasuyo Ieda, Mitsuyo Tsuma, Yumi Matsuzaki, Haruko Kawaguchi, Takashi Yagi, Shinsuke Yuasa, Jin Endo, Tomomitsu Hotta, Satoshi Ogawa, Hideyuki Okano, Ryohei Yozu, Kiyoshi Ando, Keiichi Fukuda

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

The administration of granulocyte colony-stimulating factor (G-CSF) after myocardial infarction (MI) improves cardiac function and survival rates in mice. It was also reported recently that bone marrow (BM)-derived c-kit+ cells or macrophages in the infarcted heart are associated with improvement of cardiac remodeling and function. These observations prompted us to examine whether BM-derived hematopoietic cells mobilized by G-CSF administration after MI play a beneficial role in the infarct region. A single hematopoietic stem cell from green fluorescent protein (GFP)-transgenic mice was used to reconstitute hematopoiesis in each experimental mouse. MI was then induced, and the mice received G-CSF for 10 days. In the acute phase, a number of GFP + cells showing the elongated morphology were found in the infarcted area. Most of these cells were positive for vimentin and α-smooth muscle actin but negative for CD45, indicating that they were myofibroblasts. The number of these cells was markedly enhanced by G-CSF administration, and the enhanced myofibroblast-rich repair was considered to lead to improvements of cardiac remodeling, function, and survival rate. Next, G-CSF-mobilized monocytes were harvested from the peripheral blood of GFP-transgenic mice and injected intravenously into the infarcted mice. Following this procedure, GFP+ myofibroblasts were observed in the infarcted myocardium. These results indicate that cardiac myofibroblasts are hematopoietic in origin and could arise from monocytes/macrophages. MI leads to the recruitment of monocytes, which differentiate into myofibroblasts in the infarct region. Administration of G-CSF promotes this recruitment and enhances cardiac protection.

Original languageEnglish
Pages (from-to)2750-2759
Number of pages10
JournalStem Cells
Volume25
Issue number11
DOIs
Publication statusPublished - 2007 Nov

Fingerprint

Myofibroblasts
Granulocyte Colony-Stimulating Factor
Hematopoietic Stem Cells
Myocardial Infarction
Green Fluorescent Proteins
Monocytes
Transgenic Mice
Bone Marrow
Macrophages
Hematopoiesis
Vimentin
Smooth Muscle
Actins
Myocardium
Cell Count

Keywords

  • Hematopoietic stem cells
  • Monocytes/macrophages
  • Myocardial infarction granulocyte colony-stimulating factor
  • Myofibroblasts/fibroblasts

ASJC Scopus subject areas

  • Cell Biology

Cite this

Administration of granulocyte colony-stimulating factor after myocardial infarction enhances the recruitment of hematopoietic stem cell-derived myofibroblasts and contributes to cardiac repair. / Fujita, Jun; Mori, Mitsuharu; Kawada, Hiroshi; Ieda, Yasuyo; Tsuma, Mitsuyo; Matsuzaki, Yumi; Kawaguchi, Haruko; Yagi, Takashi; Yuasa, Shinsuke; Endo, Jin; Hotta, Tomomitsu; Ogawa, Satoshi; Okano, Hideyuki; Yozu, Ryohei; Ando, Kiyoshi; Fukuda, Keiichi.

In: Stem Cells, Vol. 25, No. 11, 11.2007, p. 2750-2759.

Research output: Contribution to journalArticle

Fujita, Jun ; Mori, Mitsuharu ; Kawada, Hiroshi ; Ieda, Yasuyo ; Tsuma, Mitsuyo ; Matsuzaki, Yumi ; Kawaguchi, Haruko ; Yagi, Takashi ; Yuasa, Shinsuke ; Endo, Jin ; Hotta, Tomomitsu ; Ogawa, Satoshi ; Okano, Hideyuki ; Yozu, Ryohei ; Ando, Kiyoshi ; Fukuda, Keiichi. / Administration of granulocyte colony-stimulating factor after myocardial infarction enhances the recruitment of hematopoietic stem cell-derived myofibroblasts and contributes to cardiac repair. In: Stem Cells. 2007 ; Vol. 25, No. 11. pp. 2750-2759.
@article{028f2e3d14f74332977458b70a47c0b3,
title = "Administration of granulocyte colony-stimulating factor after myocardial infarction enhances the recruitment of hematopoietic stem cell-derived myofibroblasts and contributes to cardiac repair",
abstract = "The administration of granulocyte colony-stimulating factor (G-CSF) after myocardial infarction (MI) improves cardiac function and survival rates in mice. It was also reported recently that bone marrow (BM)-derived c-kit+ cells or macrophages in the infarcted heart are associated with improvement of cardiac remodeling and function. These observations prompted us to examine whether BM-derived hematopoietic cells mobilized by G-CSF administration after MI play a beneficial role in the infarct region. A single hematopoietic stem cell from green fluorescent protein (GFP)-transgenic mice was used to reconstitute hematopoiesis in each experimental mouse. MI was then induced, and the mice received G-CSF for 10 days. In the acute phase, a number of GFP + cells showing the elongated morphology were found in the infarcted area. Most of these cells were positive for vimentin and α-smooth muscle actin but negative for CD45, indicating that they were myofibroblasts. The number of these cells was markedly enhanced by G-CSF administration, and the enhanced myofibroblast-rich repair was considered to lead to improvements of cardiac remodeling, function, and survival rate. Next, G-CSF-mobilized monocytes were harvested from the peripheral blood of GFP-transgenic mice and injected intravenously into the infarcted mice. Following this procedure, GFP+ myofibroblasts were observed in the infarcted myocardium. These results indicate that cardiac myofibroblasts are hematopoietic in origin and could arise from monocytes/macrophages. MI leads to the recruitment of monocytes, which differentiate into myofibroblasts in the infarct region. Administration of G-CSF promotes this recruitment and enhances cardiac protection.",
keywords = "Hematopoietic stem cells, Monocytes/macrophages, Myocardial infarction granulocyte colony-stimulating factor, Myofibroblasts/fibroblasts",
author = "Jun Fujita and Mitsuharu Mori and Hiroshi Kawada and Yasuyo Ieda and Mitsuyo Tsuma and Yumi Matsuzaki and Haruko Kawaguchi and Takashi Yagi and Shinsuke Yuasa and Jin Endo and Tomomitsu Hotta and Satoshi Ogawa and Hideyuki Okano and Ryohei Yozu and Kiyoshi Ando and Keiichi Fukuda",
year = "2007",
month = "11",
doi = "10.1634/stemcells.2007-0275",
language = "English",
volume = "25",
pages = "2750--2759",
journal = "Stem Cells",
issn = "1066-5099",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - Administration of granulocyte colony-stimulating factor after myocardial infarction enhances the recruitment of hematopoietic stem cell-derived myofibroblasts and contributes to cardiac repair

AU - Fujita, Jun

AU - Mori, Mitsuharu

AU - Kawada, Hiroshi

AU - Ieda, Yasuyo

AU - Tsuma, Mitsuyo

AU - Matsuzaki, Yumi

AU - Kawaguchi, Haruko

AU - Yagi, Takashi

AU - Yuasa, Shinsuke

AU - Endo, Jin

AU - Hotta, Tomomitsu

AU - Ogawa, Satoshi

AU - Okano, Hideyuki

AU - Yozu, Ryohei

AU - Ando, Kiyoshi

AU - Fukuda, Keiichi

PY - 2007/11

Y1 - 2007/11

N2 - The administration of granulocyte colony-stimulating factor (G-CSF) after myocardial infarction (MI) improves cardiac function and survival rates in mice. It was also reported recently that bone marrow (BM)-derived c-kit+ cells or macrophages in the infarcted heart are associated with improvement of cardiac remodeling and function. These observations prompted us to examine whether BM-derived hematopoietic cells mobilized by G-CSF administration after MI play a beneficial role in the infarct region. A single hematopoietic stem cell from green fluorescent protein (GFP)-transgenic mice was used to reconstitute hematopoiesis in each experimental mouse. MI was then induced, and the mice received G-CSF for 10 days. In the acute phase, a number of GFP + cells showing the elongated morphology were found in the infarcted area. Most of these cells were positive for vimentin and α-smooth muscle actin but negative for CD45, indicating that they were myofibroblasts. The number of these cells was markedly enhanced by G-CSF administration, and the enhanced myofibroblast-rich repair was considered to lead to improvements of cardiac remodeling, function, and survival rate. Next, G-CSF-mobilized monocytes were harvested from the peripheral blood of GFP-transgenic mice and injected intravenously into the infarcted mice. Following this procedure, GFP+ myofibroblasts were observed in the infarcted myocardium. These results indicate that cardiac myofibroblasts are hematopoietic in origin and could arise from monocytes/macrophages. MI leads to the recruitment of monocytes, which differentiate into myofibroblasts in the infarct region. Administration of G-CSF promotes this recruitment and enhances cardiac protection.

AB - The administration of granulocyte colony-stimulating factor (G-CSF) after myocardial infarction (MI) improves cardiac function and survival rates in mice. It was also reported recently that bone marrow (BM)-derived c-kit+ cells or macrophages in the infarcted heart are associated with improvement of cardiac remodeling and function. These observations prompted us to examine whether BM-derived hematopoietic cells mobilized by G-CSF administration after MI play a beneficial role in the infarct region. A single hematopoietic stem cell from green fluorescent protein (GFP)-transgenic mice was used to reconstitute hematopoiesis in each experimental mouse. MI was then induced, and the mice received G-CSF for 10 days. In the acute phase, a number of GFP + cells showing the elongated morphology were found in the infarcted area. Most of these cells were positive for vimentin and α-smooth muscle actin but negative for CD45, indicating that they were myofibroblasts. The number of these cells was markedly enhanced by G-CSF administration, and the enhanced myofibroblast-rich repair was considered to lead to improvements of cardiac remodeling, function, and survival rate. Next, G-CSF-mobilized monocytes were harvested from the peripheral blood of GFP-transgenic mice and injected intravenously into the infarcted mice. Following this procedure, GFP+ myofibroblasts were observed in the infarcted myocardium. These results indicate that cardiac myofibroblasts are hematopoietic in origin and could arise from monocytes/macrophages. MI leads to the recruitment of monocytes, which differentiate into myofibroblasts in the infarct region. Administration of G-CSF promotes this recruitment and enhances cardiac protection.

KW - Hematopoietic stem cells

KW - Monocytes/macrophages

KW - Myocardial infarction granulocyte colony-stimulating factor

KW - Myofibroblasts/fibroblasts

UR - http://www.scopus.com/inward/record.url?scp=36248933189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36248933189&partnerID=8YFLogxK

U2 - 10.1634/stemcells.2007-0275

DO - 10.1634/stemcells.2007-0275

M3 - Article

C2 - 17690181

AN - SCOPUS:36248933189

VL - 25

SP - 2750

EP - 2759

JO - Stem Cells

JF - Stem Cells

SN - 1066-5099

IS - 11

ER -